Simavita Limited Annual Report 2020

Simavita Limited 24 Consolidated Notes June 30, 2020 $ June 30, 2019 $ Cash flows from /(used in) operating activities Loss for the year (4,066,402) (3,934,216) Non-cash items Depreciation and amortization 163,083 18,637 Share-based payments expenses 24,000 56,700 Unrealized foreign exchange movements (277) 3,972 Accrued interest on borrowings and convertible notes 461,641 211,721 Changes in working capital (Increase)/decrease in receivables (228,850) 97,000 (Increase)/decrease in inventories – 207,008 (Increase)/decrease in prepayments (65,097) 27,575 Increase/(decrease) in payables 201,685 (177,401) Increase/(decrease) in provisions (29,735) (17,523) Net cash flows from/(used in) operating activities (3,539,952) (3,506,527) Cash flows from/(used in) investing activities Purchases of plant and equipment (78,773) (154,181) Purchases of intangible assets – – Proceeds from the sale of plant and equipment – – Net cash flows from/(used in) investing activities (78,773) (154,181) Cash flows from/(used in) financing activities Proceeds from the issue of shares by the Company 2,920,000 2,155,000 Proceeds from borrowings 590,156 253,754 Proceeds from the issue of convertible notes 1,750,000 1,390,000 Repayment of borrowings (253,754) (708,871) Equity transaction costs (14,295) (110,183) Net cash flows from/(used in) financing activities 4,992,107 2,979,700 Net increase/(decrease) in cash and cash equivalents held 1,373,382 (681,008) Cash and cash equivalents at the beginning of year 689,462 1,361,484 Net foreign exchange differences on cash and cash equivalents – 8,986 Cash and cash equivalents at the end of year 10 2,062,844 689,462 The accompanying notes form an integral part of these consolidated financial statements Consolidated Statement of Cash Flows for the year ended June 30, 2020

RkJQdWJsaXNoZXIy MjE2NDg3